Kybella 20 mg in 2 mL Injection
RxNorm 1649980
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 1649980 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: Kybella 20 mg in 2 mL Injection.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SBDPrescribable
Semantic Branded Drug (SBD):
2 mL deoxycholic acid 10 mg/ML Injection [Kybella]
(Atom ID: 12371421)
SYPrescribable
Synonym (SY):
2 mL Kybella 10 mg/ML Injection
(Atom ID: 7239189)
PSNPrescribable
Prescribable Name (PSN):
Kybella 20 mg in 2 mL Injection
(Atom ID: 7239188)
SYPrescribable
Synonym (SY):
Kybella 20 mg per 2 mL Injection
(Atom ID: 7239193)
Patient Education
Deoxycholic Acid Injection
Deoxycholic acid injection is used to improve the appearance and profile of moderate to severe submental fat ('double chin'; fatty tissue located under the chin). Deoxycholic acid injection is in a class of medications called cytolytic medications. It works by breaking down cells in fatty tissue.
[Learn More]
* Please review the disclaimer below.